Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Object Symbol | Species | Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | Nbl1 | Rat | 14-Deoxy-11,12-didehydroandrographolide | decreases expression | ISO | NBL1 (Homo sapiens) | 6480464 | 14-deoxy-11 and 12-didehydroandrographolide results in decreased expression of NBL1 mRNA | CTD | PMID:22101062 | Nbl1 | Rat | 17beta-estradiol | increases expression | ISO | Nbl1 (Mus musculus) | 6480464 | Estradiol results in increased expression of NBL1 mRNA | CTD | PMID:19484750 | Nbl1 | Rat | 17beta-hydroxy-5alpha-androstan-3-one | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Dihydrotestosterone results in increased expression of NBL1 mRNA | CTD | PMID:29581250 | Nbl1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NBL1 mRNA | CTD | PMID:20106945 and PMID:21632981 | Nbl1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of NBL1 mRNA | CTD | PMID:34747641 | Nbl1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Nbl1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of NBL1 mRNA | CTD | PMID:26377647 | Nbl1 | Rat | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | ISO | Nbl1 (Mus musculus) | 6480464 | Tetrachlorodibenzodioxin results in increased expression of NBL1 mRNA | CTD | PMID:19933214 | Nbl1 | Rat | 2,4-dibromophenyl 2,4,5-tribromophenyl ether | affects expression | ISO | Nbl1 (Mus musculus) | 6480464 | 2 more ... | CTD | PMID:38648751 | Nbl1 | Rat | 2-methylcholine | affects expression | ISO | NBL1 (Homo sapiens) | 6480464 | beta-methylcholine affects the expression of NBL1 mRNA | CTD | PMID:21179406 | Nbl1 | Rat | 4,4'-sulfonyldiphenol | increases expression | ISO | Nbl1 (Mus musculus) | 6480464 | bisphenol S results in increased expression of NBL1 mRNA | CTD | PMID:30951980 | Nbl1 | Rat | 4,4'-sulfonyldiphenol | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NBL1 mRNA | CTD | PMID:36041667 | Nbl1 | Rat | 4,4'-sulfonyldiphenol | increases methylation | ISO | Nbl1 (Mus musculus) | 6480464 | bisphenol S results in increased methylation of NBL1 promoter | CTD | PMID:33297965 | Nbl1 | Rat | 4-hydroxyphenyl retinamide | decreases expression | ISO | Nbl1 (Mus musculus) | 6480464 | Fenretinide results in decreased expression of NBL1 mRNA | CTD | PMID:16467112 | Nbl1 | Rat | 5-fluorouracil | decreases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Fluorouracil results in decreased expression of NBL1 mRNA | CTD | PMID:16709241 | Nbl1 | Rat | 6-propyl-2-thiouracil | decreases expression | EXP | | 6480464 | Propylthiouracil results in decreased expression of NBL1 mRNA | CTD | PMID:24780913 and PMID:30047161 | Nbl1 | Rat | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of NBL1 mRNA | CTD | PMID:28959563 | Nbl1 | Rat | acrylamide | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Acrylamide results in increased expression of NBL1 mRNA | CTD | PMID:32763439 | Nbl1 | Rat | aflatoxin B1 | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of NBL1 mRNA | CTD | PMID:22100608 | Nbl1 | Rat | aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of NBL1 mRNA | CTD | PMID:33354967 | Nbl1 | Rat | all-trans-retinoic acid | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of NBL1 mRNA | CTD | PMID:17431108 | Nbl1 | Rat | alpha-Zearalanol | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of NBL1 mRNA | CTD | PMID:35163327 | Nbl1 | Rat | amitrole | decreases expression | EXP | | 6480464 | Amitrole results in decreased expression of NBL1 mRNA | CTD | PMID:30047161 | Nbl1 | Rat | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of NBL1 mRNA | CTD | PMID:16483693 | Nbl1 | Rat | amphetamine | increases expression | EXP | | 6480464 | Amphetamine results in increased expression of NBL1 mRNA | CTD | PMID:30779732 | Nbl1 | Rat | Aroclor 1254 | increases expression | ISO | Nbl1 (Mus musculus) | 6480464 | Chlorodiphenyl (54% Chlorine) results in increased expression of NBL1 mRNA | CTD | PMID:23650126 | Nbl1 | Rat | arsane | affects expression | ISO | NBL1 (Homo sapiens) | 6480464 | Arsenic affects the expression of NBL1 protein | CTD | PMID:24675094 | Nbl1 | Rat | arsenic atom | affects expression | ISO | NBL1 (Homo sapiens) | 6480464 | Arsenic affects the expression of NBL1 protein | CTD | PMID:24675094 | Nbl1 | Rat | atrazine | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Atrazine results in increased expression of NBL1 mRNA | CTD | PMID:22378314 | Nbl1 | Rat | benzo[a]pyrene | increases methylation | ISO | NBL1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased methylation of NBL1 promoter | CTD | PMID:27901495 | Nbl1 | Rat | benzo[a]pyrene | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in increased expression of NBL1 mRNA | CTD | PMID:32234424 | Nbl1 | Rat | benzo[a]pyrene | decreases expression | ISO | Nbl1 (Mus musculus) | 6480464 | Benzo(a)pyrene results in decreased expression of NBL1 mRNA | CTD | PMID:32417428 | Nbl1 | Rat | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of NBL1 mRNA | CTD | PMID:25181051 | Nbl1 | Rat | bisphenol A | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NBL1 mRNA | CTD | PMID:36041667 | Nbl1 | Rat | bisphenol A | decreases expression | EXP | | 6480464 | bisphenol A results in decreased expression of NBL1 mRNA | CTD | PMID:32145629 | Nbl1 | Rat | bisphenol A | increases expression | ISO | Nbl1 (Mus musculus) | 6480464 | bisphenol A results in increased expression of NBL1 mRNA | CTD | PMID:30951980 and PMID:32156529 | Nbl1 | Rat | bisphenol F | increases expression | ISO | Nbl1 (Mus musculus) | 6480464 | bisphenol F results in increased expression of NBL1 mRNA | CTD | PMID:30951980 | Nbl1 | Rat | bisphenol F | multiple interactions | EXP | | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in decreased expression of NBL1 mRNA | CTD | PMID:36041667 | Nbl1 | Rat | cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of NBL1 mRNA | CTD | PMID:21297351 | Nbl1 | Rat | cadmium dichloride | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Cadmium Chloride results in increased expression of NBL1 mRNA | CTD | PMID:38568856 | Nbl1 | Rat | cadmium dichloride | increases methylation | EXP | | 6480464 | Cadmium Chloride results in increased methylation of NBL1 promoter | CTD | PMID:22457795 | Nbl1 | Rat | calcitriol | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Calcitriol results in increased expression of NBL1 mRNA | CTD | PMID:21592394 | Nbl1 | Rat | calcitriol | multiple interactions | ISO | NBL1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of NBL1 mRNA | CTD | PMID:21592394 | Nbl1 | Rat | carbamazepine | affects expression | ISO | NBL1 (Homo sapiens) | 6480464 | Carbamazepine affects the expression of NBL1 mRNA | CTD | PMID:25979313 | Nbl1 | Rat | carbon nanotube | decreases expression | ISO | Nbl1 (Mus musculus) | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | Nbl1 | Rat | carmustine | affects response to substance | ISO | NBL1 (Homo sapiens) | 6480464 | NBL1 mRNA affects the susceptibility to Carmustine | CTD | PMID:16365179 | Nbl1 | Rat | choline | multiple interactions | ISO | Nbl1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NBL1 gene | CTD | PMID:20938992 | Nbl1 | Rat | chromium(6+) | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | chromium hexavalent ion results in increased expression of NBL1 protein | CTD | PMID:28596144 | Nbl1 | Rat | cisplatin | decreases expression | EXP | | 6480464 | Cisplatin results in decreased expression of NBL1 mRNA | CTD | PMID:22023808 | Nbl1 | Rat | cisplatin | multiple interactions | ISO | NBL1 (Homo sapiens) | 6480464 | [Cisplatin co-treated with jinfukang] results in increased expression of NBL1 mRNA | CTD | PMID:27392435 | Nbl1 | Rat | cobalt dichloride | decreases expression | ISO | NBL1 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of NBL1 mRNA | CTD | PMID:19376846 | Nbl1 | Rat | copper(II) chloride | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | cupric chloride results in increased expression of NBL1 mRNA | CTD | PMID:38568856 | Nbl1 | Rat | DDE | decreases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Dichlorodiphenyl Dichloroethylene results in decreased expression of NBL1 mRNA | CTD | PMID:38568856 | Nbl1 | Rat | dexamethasone | decreases expression | EXP | | 6480464 | Dexamethasone results in decreased expression of NBL1 mRNA | CTD | PMID:20032058 | Nbl1 | Rat | dexamethasone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of NBL1 mRNA] | CTD | PMID:20032058 | Nbl1 | Rat | diazinon | increases methylation | ISO | NBL1 (Homo sapiens) | 6480464 | Diazinon results in increased methylation of NBL1 gene | CTD | PMID:22964155 | Nbl1 | Rat | dibutyl phthalate | increases expression | ISO | Nbl1 (Mus musculus) | 6480464 | Dibutyl Phthalate results in increased expression of NBL1 mRNA | CTD | PMID:21266533 | Nbl1 | Rat | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of NBL1 mRNA | CTD | PMID:21266533 | Nbl1 | Rat | dimethylarsinic acid | increases expression | EXP | | 6480464 | Cacodylic Acid results in increased expression of NBL1 mRNA | CTD | PMID:16122865 | Nbl1 | Rat | diuron | decreases expression | EXP | | 6480464 | Diuron results in decreased expression of NBL1 mRNA | CTD | PMID:21551480 and PMID:25152437 | Nbl1 | Rat | dorsomorphin | multiple interactions | ISO | NBL1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NBL1 mRNA | CTD | PMID:27188386 | Nbl1 | Rat | doxorubicin | decreases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of NBL1 mRNA | CTD | PMID:29803840 | Nbl1 | Rat | endosulfan | affects expression | EXP | | 6480464 | Endosulfan affects the expression of NBL1 mRNA | CTD | PMID:29391264 | Nbl1 | Rat | entinostat | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | entinostat results in increased expression of NBL1 mRNA | CTD | PMID:27188386 | Nbl1 | Rat | folic acid | multiple interactions | ISO | Nbl1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NBL1 gene | CTD | PMID:20938992 | Nbl1 | Rat | furan | increases expression | EXP | | 6480464 | furan results in increased expression of NBL1 mRNA | CTD | PMID:27387713 | Nbl1 | Rat | gentamycin | increases expression | EXP | | 6480464 | Gentamicins results in increased expression of NBL1 mRNA | CTD | PMID:33387578 | Nbl1 | Rat | glycine betaine | increases expression | EXP | | 6480464 | Betaine results in increased expression of NBL1 mRNA | CTD | PMID:26391144 | Nbl1 | Rat | L-methionine | multiple interactions | ISO | Nbl1 (Mus musculus) | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of NBL1 gene | CTD | PMID:20938992 | Nbl1 | Rat | lead diacetate | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | lead acetate results in increased expression of NBL1 mRNA | CTD | PMID:38568856 | Nbl1 | Rat | lead(0) | affects expression | ISO | NBL1 (Homo sapiens) | 6480464 | Lead affects the expression of NBL1 mRNA | CTD | PMID:28903495 | Nbl1 | Rat | methimazole | decreases expression | EXP | | 6480464 | Methimazole results in decreased expression of NBL1 mRNA | CTD | PMID:30047161 | Nbl1 | Rat | methotrexate | decreases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Methotrexate results in decreased expression of NBL1 mRNA | CTD | PMID:17400583 | Nbl1 | Rat | methylmercury chloride | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | methylmercuric chloride results in increased expression of NBL1 mRNA | CTD | PMID:28001369 | Nbl1 | Rat | methylparaben | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | methylparaben results in increased expression of NBL1 mRNA | CTD | PMID:38568856 | Nbl1 | Rat | N-methyl-N'-nitro-N-nitrosoguanidine | decreases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Methylnitronitrosoguanidine results in decreased expression of NBL1 mRNA | CTD | PMID:12634122 | Nbl1 | Rat | nitrofen | decreases expression | EXP | | 6480464 | nitrofen results in decreased expression of NBL1 mRNA | CTD | PMID:26720608 | Nbl1 | Rat | O-methyleugenol | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | methyleugenol results in increased expression of NBL1 mRNA | CTD | PMID:32234424 | Nbl1 | Rat | paracetamol | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Acetaminophen results in increased expression of NBL1 mRNA | CTD | PMID:22230336 | Nbl1 | Rat | paracetamol | decreases expression | EXP | | 6480464 | Acetaminophen results in decreased expression of NBL1 mRNA | CTD | PMID:33387578 | Nbl1 | Rat | perfluorohexanesulfonic acid | increases expression | ISO | Nbl1 (Mus musculus) | 6480464 | perfluorohexanesulfonic acid results in increased expression of NBL1 mRNA | CTD | PMID:37995155 | Nbl1 | Rat | perfluorononanoic acid | decreases expression | ISO | NBL1 (Homo sapiens) | 6480464 | perfluoro-n-nonanoic acid results in decreased expression of NBL1 mRNA | CTD | PMID:38568856 | Nbl1 | Rat | perfluorooctanoic acid | multiple interactions | EXP | | 6480464 | [Zeranol co-treated with perfluorooctanoic acid] results in increased expression of NBL1 mRNA | CTD | PMID:35163327 | Nbl1 | Rat | propylparaben | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | propylparaben results in increased expression of NBL1 mRNA | CTD | PMID:38568856 | Nbl1 | Rat | raloxifene | increases expression | EXP | | 6480464 | Raloxifene Hydrochloride results in increased expression of NBL1 mRNA | CTD | PMID:15576828 | Nbl1 | Rat | SB 431542 | multiple interactions | ISO | NBL1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NBL1 mRNA | CTD | PMID:27188386 | Nbl1 | Rat | silver atom | decreases expression | ISO | Nbl1 (Mus musculus) | 6480464 | Silver results in decreased expression of NBL1 mRNA | CTD | PMID:27131904 | Nbl1 | Rat | silver(0) | decreases expression | ISO | Nbl1 (Mus musculus) | 6480464 | Silver results in decreased expression of NBL1 mRNA | CTD | PMID:27131904 | Nbl1 | Rat | sodium arsenite | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | sodium arsenite results in increased expression of NBL1 mRNA | CTD | PMID:38568856 | Nbl1 | Rat | sodium arsenite | decreases expression | ISO | Nbl1 (Mus musculus) | 6480464 | sodium arsenite results in decreased expression of NBL1 mRNA | CTD | PMID:36209798 and PMID:37682722 | Nbl1 | Rat | sulfadimethoxine | decreases expression | EXP | | 6480464 | Sulfadimethoxine results in decreased expression of NBL1 mRNA | CTD | PMID:30047161 | Nbl1 | Rat | temozolomide | affects response to substance | ISO | NBL1 (Homo sapiens) | 6480464 | NBL1 mRNA affects the susceptibility to temozolomide | CTD | PMID:16365179 | Nbl1 | Rat | temozolomide | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Temozolomide results in increased expression of NBL1 mRNA | CTD | PMID:31758290 | Nbl1 | Rat | testosterone | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Testosterone results in increased expression of NBL1 mRNA | CTD | PMID:21592394 | Nbl1 | Rat | testosterone | increases expression | ISO | Nbl1 (Mus musculus) | 6480464 | Testosterone deficiency results in increased expression of NBL1 mRNA | CTD | PMID:33848595 | Nbl1 | Rat | testosterone | multiple interactions | ISO | NBL1 (Homo sapiens) | 6480464 | [Testosterone co-treated with Calcitriol] results in increased expression of NBL1 mRNA | CTD | PMID:21592394 | Nbl1 | Rat | testosterone | multiple interactions | EXP | | 6480464 | Testosterone inhibits the reaction [Dexamethasone results in decreased expression of NBL1 mRNA] | CTD | PMID:20032058 | Nbl1 | Rat | thiram | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Thiram results in increased expression of NBL1 mRNA | CTD | PMID:38568856 | Nbl1 | Rat | trichloroethene | increases expression | ISO | Nbl1 (Mus musculus) | 6480464 | Trichloroethylene results in increased expression of NBL1 mRNA | CTD | PMID:15363585 | Nbl1 | Rat | trichostatin A | decreases expression | ISO | NBL1 (Homo sapiens) | 6480464 | trichostatin A results in decreased expression of NBL1 mRNA | CTD | PMID:24935251 | Nbl1 | Rat | valproic acid | affects expression | ISO | Nbl1 (Mus musculus) | 6480464 | Valproic Acid affects the expression of NBL1 mRNA | CTD | PMID:17963808 | Nbl1 | Rat | valproic acid | multiple interactions | ISO | NBL1 (Homo sapiens) | 6480464 | [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of NBL1 mRNA | CTD | PMID:27188386 | Nbl1 | Rat | valproic acid | decreases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased expression of NBL1 mRNA | CTD | PMID:23179753 and PMID:26272509 | Nbl1 | Rat | valproic acid | increases methylation | ISO | NBL1 (Homo sapiens) | 6480464 | Valproic Acid results in increased methylation of NBL1 gene | CTD | PMID:29154799 | Nbl1 | Rat | valproic acid | increases expression | ISO | NBL1 (Homo sapiens) | 6480464 | Valproic Acid results in increased expression of NBL1 mRNA | CTD | PMID:23179753 | Nbl1 | Rat | valproic acid | affects expression | ISO | NBL1 (Homo sapiens) | 6480464 | Valproic Acid affects the expression of NBL1 mRNA | CTD | PMID:25979313 | Nbl1 | Rat | vinclozolin | decreases expression | EXP | | 6480464 | vinclozolin results in decreased expression of NBL1 mRNA | CTD | PMID:23034163 | |